Page last updated: 2024-08-26

norcantharidin and Leukemia

norcantharidin has been researched along with Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anjo, A; Blazsek, I; Comisso, M; Legras, S; Liu, XH; Marion, S; Misset, JL; Quittet, P; Wang, GS	1

Other Studies

1 other study(ies) available for norcantharidin and Leukemia

Article	Year
Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:6 Topics: Animals; Antineoplastic Agents; Bone Marrow; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Leukemia; Leukocyte Count; Leukocytes; Leukocytosis; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Tumor Cells, Cultured	1995

Article

Year

Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells.

European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:6

Topics: Animals; Antineoplastic Agents; Bone Marrow; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Leukemia; Leukocyte Count; Leukocytes; Leukocytosis; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Tumor Cells, Cultured

1995